I-Retagliptin

Igama Lekhemikhali:

(R) -methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine- I-1-carboxylate phosphate

Ikhodi ye-SMILES:

COC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C (F)(F)F)=O

Ikhodi ye-InChi:

I-InChI=1S/C19H19F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(3 0)6-10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10,18H,2-4,6,8,26H2,1H3/ t10-,18?/m1/s1

I-InChi Key:

I-FXBCTRLEFVUDDC-DMPGVRBJSA-N

Igama elingukhiye:

I-Retagliptin, SP-2086,SP2086,1174122-54-3, 1256756-88-3

Ukunyibilika:I-Soluble ku-DMSO

Isitoreji:0 - 4°C isikhathi esifushane (izinsuku ukuya emavikini), noma -20°C isikhathi eside (izinyanga).

Incazelo:

I-Retagliptin, eyaziwa nangokuthi i-SP-2086, iyi-DPP-4 inhibitor engase isetshenziselwe ukwelapha uhlobo 2 sikashukela.

Ithagethi: DPP-4